CHI Advisors LLC
- SEC CIK
- 0001791468
- 最新申報
- 2023/11/13
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/15 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 19
- 較 2021 年第 2 季 +1
- 總值
- $3.43 億
- 較 2021 年第 2 季 −$8,728 萬 (−20.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 2,862,059 | $6,786 萬 | 19.8% | +10,050+0.4% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 2,232,783 | $5,859 萬 | 17.1% | −306,861−12.1% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 2,244,841 | $5,067 萬 | 14.8% | +2,000+0.1% | 加碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 2,484,724 | $4,194 萬 | 12.2% | +116,836+4.9% | 加碼 | 歷史 |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 2,592,602 | $2,003 萬 | 5.8% | +6,616+0.3% | 加碼 | – |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 1,055,882 | $1,990 萬 | 5.8% | +1,055,882 | 新進 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 1,515,148 | $1,747 萬 | 5.1% | 00.0% | 不變 | 歷史 |
| ONCROncorus, Inc. | COM | 1,755,979 | $1,640 萬 | 4.8% | +20,000+1.2% | 加碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 920,264 | $1,067 萬 | 3.1% | −7,000−0.8% | 減碼 | 歷史 |
| AKUSAkouos, Inc. | COM | 858,027 | $996.2 萬 | 2.9% | 00.0% | 不變 | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 4,081,972 | $938.8 萬 | 2.7% | 00.0% | 不變 | 歷史 |
| DTILPrecision Biosciences Inc | COM | 646,729 | $746.3 萬 | 2.2% | −5,000−0.8% | 減碼 | 歷史 |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,427,481 | $486.7 萬 | 1.4% | +47,638+3.5% | 加碼 | – |
| IMAImageneBio, Inc. | COM | 315,000 | $397.5 萬 | 1.2% | −499,756−61.3% | 減碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 165,927 | $80.3 萬 | 0.2% | −553,205−76.9% | 減碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 233,510 | $78.5 萬 | 0.2% | +15,000+6.9% | 加碼 | 歷史 |
| GTHXG1 Therapeutics, Inc. | COM | 50,000 | $67.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 75,000 | $64.8 萬 | 0.2% | −71,680−48.9% | 減碼 | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 12,627 | $50.0 萬 | 0.1% | −103,779−89.2% | 減碼 | 歷史 |